InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,736.37
(
0.25%
)
US TECH 100
19,572.20
(
0.72%
)
Dow Jones
42,121.51
(
0.49%
)
Brent Oil
71.42
(
-2.43%
)
Bitcoin
64,627.56
(
2.36%
)
Post# of 14015
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DR5

Send PM Follow Ignore
Followers 10
Posts 1118
Boards Moderated 0
Alias Born 01/05/2018

DR5

Re: None

Tuesday, 09/11/2018 11:17:26 AM

Tuesday, September 11, 2018 11:17:26 AM

Post# of 14015
Hey guys/gals, I noticed in the study design that if HemoStyp is found to be “non-inferior” to SurgiCel as the primary outcome then they will evaluate “superiority” to SurgiCel.
IMO, this is a foregone conclusion and if both endpoints are satisfied, this will be a defining moment for United. We just sit back and enjoy a handsome return on our investment.
GLTA! (Longs)
DR5
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent UEEC News
More UEEC News
InvestorsHub NewsWire

Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM

Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM

North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM

CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM

Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM

Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM

Start posting your company's news
Only $200 per official company press release!